Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(S)-ML753286 is a breast cancer resistance protein (BCRP) inhibitor (IC50: 0.6 μM on BCRP efflux transporter).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 6-8 weeks | $ 523.00 | |
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 | |
1 mL * 10 mM (in DMSO) | 6-8 weeks | $ 514.00 |
Description | (S)-ML753286 is a breast cancer resistance protein (BCRP) inhibitor (IC50: 0.6 μM on BCRP efflux transporter). |
Targets&IC50 | BCRP (Pheo A):0.6 μM |
In vivo | (S)-ML753286 (Compound A) shows the potency and a potent pharmacokinetic (PK) profile in rats (lower clearance [1.54 L/h/kg] and higher bioavailability [123%]). |
Molecular Weight | 355.43 |
Formula | C20H25N3O3 |
CAS No. | 1699720-85-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (140.67 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(S)-ML753286 1699720-85-8 Others ML-753286 ML753286 (S) ML753286 ML 753286 (S)-ML-753286 (S)ML753286 inhibitor inhibit